Results 11 to 20 of about 893,284 (261)

Systemic Scleroderma—Definition, Clinical Picture and Laboratory Diagnostics [PDF]

Journal of Clinical Medicine, 2022
(1) Background: Scleroderma (Sc) is a rare connective tissue disease classified as an autoimmune disorder. The pathogenesis of this disease is not fully understood. (2) Methods: This article reviews the literature on systemic scleroderma (SSc).
Anna Kowalska-Kępczyńska
exaly   +3 more sources

Antiphospholipid Antibodies and Systemic Scleroderma

Turkish Journal of Hematology, 2013
Objective: Antiphospholipid antibodies (APLs) could be associated with an increased risk of vascular pathologies in systemic scleroderma. The aim of our study was to search for APLs in patients affected by systemic scleroderma and to evaluate their ...
Awa Oumar Touré, Fatimata Ly, Abibatou Sall, Alassane Diatta, Macoura Gadji, Moussa Seck, Blaise Faye, Tandakha Dieye, Saliou Diop   +8 more
doaj   +2 more sources

Scleroderma with Nodular Scleroderma

Case Reports in Dermatology, 2016
Background: Nodular scleroderma is a rare variant of scleroderma which can occur in connection with systemic sclerosis or morphea. A biopsy from the lesion can demonstrate the scleroderma pattern, i.e., keloid pattern or mixed type.
Chutika Srisuttiyakorn, Kobkul Aunhachoke   +1 more
doaj   +2 more sources

Systemic Scleroderma in Childhood: A Case Report

The Turkish Journal of Gastroenterology, 2014
Juvenile systemic scleroderma is a rare chronic multi-system connective tissue disease in childhood. Although rare in children, it is an important cause of morbidity and mortality.
Aslı ASLAN, Güldane KOTUROĞLU, Betül SÖZERİ, Zafer KURUGÖL   +3 more
doaj   +2 more sources

Sine scleroderma, limited cutaneous, and diffused cutaneous systemic sclerosis survival and predictors of mortality

Arthritis Research & Therapy, 2021
Highlights • Male sex, cardiac involvement, DLCO 5 mg/l are strong predictors of mortality in systemic sclerosis. • This study shows the survival of subtypes and in particular sine scleroderma. • Sine scleroderma subtype has better survival than diffuse
Sébastien De Almeida Chaves, Tiphaine Porel, Mickael Mounié, Laurent Alric, Léonardo Astudillo, Antoine Huart, Olivier Lairez, Martin Michaud, Grégoire Prévot, David Ribes, Laurent Sailler, Francis Gaches, Daniel Adoue, Gregory Pugnet   +13 more
doaj   +2 more sources

DIAGNOSTIC VALUE OF CERULOPLASMIN IN SYSTEMIC SCLERODERMA [PDF]

Медицинская иммунология, 2019
Objective of study: refining immune diagnostics of systemic scleroderma through determining ceruloplasmin antibodies, its amount and enzymatic activity, as well as control of effectiveness of therapy with ceruloplasmin-based immobilized ...
O. I. Emelyanova, I. P. Gontar, O. A. Rusanova, I. A. Zborovskaya   +3 more
doaj   +2 more sources

Prevalence of Oral and Maxillofacial Disorders in Patients with Systemic Scleroderma—A Systematic Review [PDF]

International Journal of Environmental Research and Public Health, 2021
Stephanie Knippschild, Korbinian Benz, Jochen Jackowski   +2 more
exaly   +2 more sources

Barriers to care in juvenile localized and systemic scleroderma: an exploratory survey study of caregivers' perspectives. [PDF]

Pediatr Rheumatol Online J, 2023
BACKGROUND: Juvenile localized scleroderma (LS) and systemic sclerosis (SSc) are rare pediatric conditions often associated with severe morbidities. Delays in diagnosis are common, increasing the risk for permanent damage and worse outcomes.
Stubbs LA, Ferry AM, Guffey D, Loccke C, Wade EM, Pour P, Ardalan K, Chira P, Ganske IM, Glaser D, Higgins G, Luca N, Moore KF, Sivaraman V, Stewart K, Vasquez-Canizares N, Hunt RD, Maricevich RS, Torok KS, Li SC, Childhood Arthritis, Rheumatology Research Alliance (CARRA) Scleroderma Workgroup.   +21 more
europepmc   +2 more sources

Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc

Arthritis Research & Therapy, 2023
Background The study of molecular mechanisms characterizing disease progression may be relevant to get insights into systemic sclerosis (SSc) pathogenesis and to intercept patients at very early stage.
Chiara Bellocchi, Shervin Assassi, Marka Lyons, Maurizio Marchini, Chandra Mohan, Alessandro Santaniello, Lorenzo Beretta   +6 more
doaj   +1 more source

Fibrosing arthropathy in juvenile scleroderma

Современная ревматология, 2021
The group of scleroderma diseases includes a number of clinical entities, the main symptom of which is skin tightening. Scleroderma is a prominent example of these diseases, characterized by excessive synthesis and deposition of collagen in organs and ...
D. A. Dibrov, M. N. Starovoitova, O. V. Desinova   +2 more
doaj   +1 more source